Baseline maximum standardised uptake value does not predict outcomes in high‐tumour‐burden follicular lymphoma treated with first‐line immunochemotherapy
Baseline maximum standardised uptake value does not predict survival in high-tumour-burden follicular lymphoma treated with first-line immunochemotherapy, but identifies patients at risk of histological transformation: no transformation occurred below the cohort median. Its role is to guide biopsy and surveillance rather than therapeutic stratification.
Authors
- Paul Coppo (ORCID: https://orcid.org/0000-0002-4618-2095)
- Fazia Kaoui
- Florent Malard (ORCID: https://orcid.org/0000-0002-3474-0002)
- Zoé Van de Wyngaert (ORCID: https://orcid.org/0000-0001-9463-2823)
- Nicolas Stocker (ORCID: https://orcid.org/0000-0001-7316-5832)
- Laure Ricard (ORCID: https://orcid.org/0000-0003-4416-3285)
- Zora Marjanovic (ORCID: https://orcid.org/0000-0002-5391-5875)
- Bénédicte Jonca
- Elise Corre
- Ikram Bouguern
- Mohamad Mohty
Institutions
- Inserm (FR)
- Université Paris Cité (FR)
- Sorbonne Université (FR)
- Centre de Recherche des Cordeliers (FR)
- Hôpital Saint-Antoine (FR)
- Centre de Recherche Saint-Antoine (FR)
- Hôpital Tenon (FR)
Publication Details
- Journal
- British Journal of Haematology
- Published
- 2026-11-03
- DOI
- https://doi.org/10.1111/bjh.70936
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00